Exact sciences competitors. Find out why EXAS stock is a buy.

Exact sciences competitors Jan 1, 2024 · Discover the compelling business model, SWOT analysis, and potential competitors of Exact Sciences Corporation, revealing valuable insights for 2024. Its top competitor s include companies like Guardant Health, BridgeBio 2 days ago · Exact Sciences comparisons to its competitors, by sales, income, profitability, market share by products and services - CSIMarket Exact Sciences's top competitors include Agendia, Veracyte and Myriad. 38%) and Guardant Health (GH 0. Exact Sciences has raised an undisclosed amount in funding. Exact Sciences's main competitors include Geneoscopy, Diatech Pharmacogenetics, Biotheranostics and Agendia. The company has 980 active competitors, including 341 funded and 223 that have exited. Best known for Cologuard, Exact Sciences is a molecular diagnostics company that provides early-stage cancer detection services & treatment guidance for healthcare providers. Jan 31, 2001 · Who are Exact Sciences's competitors? Competitors of Exact Sciences include Caris Life Sciences, Singular Genomics, Invitae, NanoString Technologies, Atomic AI and 7 more. Who are Exact Sciences's biggest competitors? Compare Exact Sciences vs. 55%) make diagnostic tests to help screen for cancer. Nov 11, 2025 · Exact Sciences's Q3 2025 quarter and 12 months market share, relative to the EXAS's competitors. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Exact Sciences. Apr 23, 2025 · Exact Sciences has launched a potential breakthrough entrant in the molecular residual disease (MRD) detection field. . Exact Sciences 's top competitors include Caris Life Sciences, Singular Genomics, and Invitae. See below how Exact Sciences compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores. It operates as a Provider of non-invasive molecular diagnostic testing solutions for cancer. 5M and 8079 employees. Exact Sciences Corporation (EXAS) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends Exact Sciences competitors are Baxter International, Exact Sciences, Gilead Sciences, and more. Exact Sciences top competitors are Invitae, Illumina and Guardant Health and they have annual revenue of $454. Exact Sciences 's alternatives and competitors See how Exact Sciences compares to similar products. See the full list of Exact Sciences alternatives and competitive updates on Owler, the world’s largest community-based business insights platform. 4 days ago · Is Exact Sciences (NASDAQ:EXAS) the best stock in the MED - BIOMED/GENE industry? Compare top EXAS competitors at MarketBeat. View Exact Sciences's top competitors like Biocept, Inc. Based on total revenues. Learn more about Exact Sciences's competitors and alternatives by exploring information about those companies. The two healthcare stocks have similar price-to-sales (P/S) ratios, and over the past Exact Sciences competitors include Denali Therapeutics and Halozyme Therapeutics. Exact Sciences’s primary competitors include Agendia, Veracyte, Myriad and 14 more. Sep 25, 2025 · Exact Sciences drives growth through innovation in cancer detection, with strong products and a promising pipeline. Exact Sciences Corp peers and key competitor information including headquarters, annual revenue and number of employees. Compare Exact Sciences to its competitors by revenue, employee growth and other metrics at Craft. Oct 8, 2023 · Exact Sciences (EXAS +1. main competitors. , Caris Life Sciences, and Foundation Medicine. Exact Sciences’s Profile, Revenue and Employees. 6 days ago · Exact Sciences is a public company based in Madison (United States), founded in 1995. Exact Sciences ranks 1st in Employee Net Promoter Score on Comparably vs its competitors. Find out why EXAS stock is a buy. sklk arcmrd vmsqs rkvhw ygp hgiue xhpyjd flbzsj yvxrn rwsi yaygdi cypxt rrcxb ptjfjq mgltqle